3/3
01:30 pm
rckt
Wedbush sees Rocket Pharmaceuticals as significantly undervalued as cardiac gene therapy pipeline advances [Yahoo! Finance]
Low
Report
Wedbush sees Rocket Pharmaceuticals as significantly undervalued as cardiac gene therapy pipeline advances [Yahoo! Finance]
3/2
12:36 pm
rckt
Rocket Pharmaceuticals (RCKT) had its price target raised by The Goldman Sachs Group, Inc. from $2.00 to $3.00. They now have a "sell" rating on the stock.
Low
Report
Rocket Pharmaceuticals (RCKT) had its price target raised by The Goldman Sachs Group, Inc. from $2.00 to $3.00. They now have a "sell" rating on the stock.
2/28
05:57 am
rckt
Rocket Pharmaceuticals (RCKT) was upgraded by Lifesci Capital to "strong-buy".
Low
Report
Rocket Pharmaceuticals (RCKT) was upgraded by Lifesci Capital to "strong-buy".
2/27
03:02 pm
rckt
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus [Yahoo! Finance]
Low
Report
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus [Yahoo! Finance]
2/27
09:47 am
rckt
Rocket Pharmaceuticals (RCKT) had its price target raised by Cantor Fitzgerald from $8.00 to $10.00. They now have an "overweight" rating on the stock.
Medium
Report
Rocket Pharmaceuticals (RCKT) had its price target raised by Cantor Fitzgerald from $8.00 to $10.00. They now have an "overweight" rating on the stock.
2/26
04:14 pm
rckt
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]
High
Report
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]
2/26
04:00 pm
rckt
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
High
Report
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
2/23
07:17 am
rckt
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/23
07:00 am
rckt
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Medium
Report
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
1/8
10:05 am
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) was given a new $5.00 price target on by analysts at Morgan Stanley.
Low
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) was given a new $5.00 price target on by analysts at Morgan Stanley.
1/5
07:00 am
rckt
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/26
10:24 am
rckt
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program [Seeking Alpha]
Low
Report
Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program [Seeking Alpha]
12/20
07:27 am
rckt
Rocket Pharmaceuticals (NASDAQ:RCKT) was upgraded by analysts at TD Cowen to a "hold" rating.
Medium
Report
Rocket Pharmaceuticals (NASDAQ:RCKT) was upgraded by analysts at TD Cowen to a "hold" rating.
12/17
07:22 am
rckt
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders [Yahoo! Finance]
12/15
11:16 pm
rckt
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position [Yahoo! Finance]
Low
Report
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position [Yahoo! Finance]